XML 15 R8.htm IDEA: XBRL DOCUMENT v3.25.3
UNAUDITED CONDENSED STATEMENTS OF CASH FLOWS - USD ($)
 3 Months Ended 9 Months Ended
Sep. 30, 2025
Sep. 30, 2025
Sep. 30, 2024
Cash flows from operating activities:      
Net income   $ 51,703  
Adjustments to reconcile net income to net cash used in operating activities      
Allocated expense for warrant issuance cost $ 1,062 103,033  
Interest reinvested in the Trust Account   (6,013,852)  
Loss from change in fair value of public warrant liabilities 1,524,900 5,292,300  
Changes in operating assets and liabilities:      
Prepaid assets   (447,993)  
Accrued expenses, formation and offering costs   601,441 $ (49,101)
Net cash used in operating activities   (413,368) (49,101)
Cash flows from investing activities:      
Cash deposited in Trust Account   (358,800,000)  
Net cash used in investing activities   (358,800,000)  
Cash flows from financing activities:      
Proceeds from sale of Units in initial public offering   358,800,000  
Proceeds from sale of Private Placement Shares to Sponsor   2,250,000  
Deferred offering costs   (461,412)  
Payment of accrued offering costs   (746,871)  
Payment of underwriters' discounts and commissions   (250,000)  
Proceeds from notes payable - related party   59,000 49,101
Repayment of notes payable - related party   (231,901)  
Net cash provided by financing activities   359,418,816  
Net change in cash   205,448  
Cash at beginning of period   2,774 2,774
Cash at end of period $ 208,222 208,222 $ 2,774
Supplemental disclosure of non-cash financing activities:      
Offering costs included in accrued expenses, formation and offering costs   1,521,318  
Advisory fee   10,764,000  
Deferred underwriting compensation   10,764,000  
Offering costs charged to additional paid in capital   2,362,108  
Initial classification of warrant liability - public   $ 1,524,900